ID

45800

Description

Principal Investigator: Steven Finkbeiner, Gladstone Institutes, San Francesco, CA, USA MeSH: Huntington Disease,Degenerative Hereditary Diseases, Nervous System,Cell Death,Brain Diseases,Ataxia,Chorea,Cognition Disorders,Dyskinesias,Mental Disorders https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001071 The goal of our studies is to identify genetic modifiers of neurodegeneration in Huntington's disease (HD). HD is caused by expansion of CAG repeats in the huntingtin (Htt) gene, with longer stretches often leading to more rapid disease onset and progression. Yet, for a given number of repeats, the age of symptom onset can be variable, differing by up to decades. Thus, the age of onset of motor symptoms in HD is only partly explained by the length of the CAG expansion. Available evidence suggests that genetic modifiers contribute to the variation in HD onset. Identifying genetic modifiers is important because they may provide critical insights into HD pathogenesis and reveal key pathways that could be targeted by novel HD therapeutics. This is important since there are no disease-modifying therapies for HD, and mHtt is an unattractive small-molecule drug target. We recruited 21 HD families with varying characteristics of disease progression and age of onset and obtained medical histories, clinical records and DNA samples that were subjected to whole-genome sequencing (WGS). These WGS data describe families of 104 subjects, including HD patients and their unaffected family members. These individuals were selected based on individual clinical histories and family structures that best fit our criteria for expressing potential genetic modifiers. We are testing the hypothesis that novel, rare genetic variants contribute to HD and those genetic modifiers can be identified by WGS.

Lien

dbGaP-study=phs001071

Mots-clés

  1. 2023-06-23 2023-06-23 - Chiara Middel
Détendeur de droits

Steven Finkbeiner, Gladstone Institutes, San Francesco, CA, USA

Téléchargé le

23 juni 2023

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

dbGaP phs001071 NINDS Family-Based Whole-Genome Sequencing to Find HD Modifiers

Eligibility Criteria

Inclusion and exclusion criteria
Description

Inclusion and exclusion criteria

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C0680251
*Inclusion criteria*:
Description

Elig.phs001071.v1.p1.1

Type de données

boolean

Alias
UMLS CUI [1,1]
C1512693
Subjects are able to provide informed consent
Description

Elig.phs001071.v1.p1.2

Type de données

boolean

Alias
UMLS CUI [1,1]
C0085732
UMLS CUI [1,2]
C0021430
Index subjects with the HD gene previously identified, with or without clinical symptoms of the disease. Spouses, adult children, siblings, and parents of the index subject, regardless of previous HD test status or desire to obtain HD diagnostic testing.
Description

Elig.phs001071.v1.p1.3

Type de données

boolean

Alias
UMLS CUI [1,1]
C2597943
UMLS CUI [1,2]
C0020179
UMLS CUI [1,3]
C0017337
UMLS CUI [1,4]
C0205396
UMLS CUI [1,5]
C0205210
UMLS CUI [1,6]
C1457887
UMLS CUI [2,1]
C2597943
UMLS CUI [2,2]
C0020179
UMLS CUI [2,3]
C0017337
UMLS CUI [2,4]
C0205396
UMLS CUI [2,5]
C0205210
UMLS CUI [2,6]
C0332288
UMLS CUI [2,7]
C1457887
UMLS CUI [3,1]
C2597943
UMLS CUI [3,2]
C0162409
UMLS CUI [3,3]
C0001675
UMLS CUI [3,4]
C0008059
UMLS CUI [3,5]
C0037047
UMLS CUI [3,6]
C0030551
UMLS CUI [3,7]
C0332291
UMLS CUI [3,8]
C0205156
UMLS CUI [3,9]
C0020179
UMLS CUI [3,10]
C0456984
UMLS CUI [3,11]
C0449438
UMLS CUI [3,12]
C0871633
UMLS CUI [3,13]
C0086143
Subjects over age 21 of either gender. *Exclusion criteria*:
Description

Elig.phs001071.v1.p1.4

Type de données

boolean

Alias
UMLS CUI [1,1]
C0001779
UMLS CUI [1,2]
C0079399
UMLS CUI [2,1]
C0680251
Subjects with wound healing or immunodeficiency disorders will be excluded to further minimize risk of skin biopsy.
Description

Elig.phs001071.v1.p1.5

Type de données

boolean

Alias
UMLS CUI [1,1]
C0151692
UMLS CUI [1,2]
C0021051
UMLS CUI [1,3]
C1524031
UMLS CUI [1,4]
C0035647
UMLS CUI [1,5]
C0150866
Subjects with allergy to the local anesthetic agents used in skin biopsy. Subjects who, in the opinion of the study PI, should not participate in this research study.
Description

Elig.phs001071.v1.p1.6

Type de données

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0002934
UMLS CUI [1,3]
C0150866
UMLS CUI [2,1]
C1521895
UMLS CUI [2,2]
C0022423
UMLS CUI [2,3]
C0679823
UMLS CUI [2,4]
C1518422
UMLS CUI [2,5]
C0034866

Similar models

Eligibility Criteria

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Inclusion and exclusion criteria
C1512693 (UMLS CUI [1,1])
C0680251 (UMLS CUI [1,2])
Elig.phs001071.v1.p1.1
Item
*Inclusion criteria*:
boolean
C1512693 (UMLS CUI [1,1])
Elig.phs001071.v1.p1.2
Item
Subjects are able to provide informed consent
boolean
C0085732 (UMLS CUI [1,1])
C0021430 (UMLS CUI [1,2])
Elig.phs001071.v1.p1.3
Item
Index subjects with the HD gene previously identified, with or without clinical symptoms of the disease. Spouses, adult children, siblings, and parents of the index subject, regardless of previous HD test status or desire to obtain HD diagnostic testing.
boolean
C2597943 (UMLS CUI [1,1])
C0020179 (UMLS CUI [1,2])
C0017337 (UMLS CUI [1,3])
C0205396 (UMLS CUI [1,4])
C0205210 (UMLS CUI [1,5])
C1457887 (UMLS CUI [1,6])
C2597943 (UMLS CUI [2,1])
C0020179 (UMLS CUI [2,2])
C0017337 (UMLS CUI [2,3])
C0205396 (UMLS CUI [2,4])
C0205210 (UMLS CUI [2,5])
C0332288 (UMLS CUI [2,6])
C1457887 (UMLS CUI [2,7])
C2597943 (UMLS CUI [3,1])
C0162409 (UMLS CUI [3,2])
C0001675 (UMLS CUI [3,3])
C0008059 (UMLS CUI [3,4])
C0037047 (UMLS CUI [3,5])
C0030551 (UMLS CUI [3,6])
C0332291 (UMLS CUI [3,7])
C0205156 (UMLS CUI [3,8])
C0020179 (UMLS CUI [3,9])
C0456984 (UMLS CUI [3,10])
C0449438 (UMLS CUI [3,11])
C0871633 (UMLS CUI [3,12])
C0086143 (UMLS CUI [3,13])
Elig.phs001071.v1.p1.4
Item
Subjects over age 21 of either gender. *Exclusion criteria*:
boolean
C0001779 (UMLS CUI [1,1])
C0079399 (UMLS CUI [1,2])
C0680251 (UMLS CUI [2,1])
Elig.phs001071.v1.p1.5
Item
Subjects with wound healing or immunodeficiency disorders will be excluded to further minimize risk of skin biopsy.
boolean
C0151692 (UMLS CUI [1,1])
C0021051 (UMLS CUI [1,2])
C1524031 (UMLS CUI [1,3])
C0035647 (UMLS CUI [1,4])
C0150866 (UMLS CUI [1,5])
Elig.phs001071.v1.p1.6
Item
Subjects with allergy to the local anesthetic agents used in skin biopsy. Subjects who, in the opinion of the study PI, should not participate in this research study.
boolean
C0020517 (UMLS CUI [1,1])
C0002934 (UMLS CUI [1,2])
C0150866 (UMLS CUI [1,3])
C1521895 (UMLS CUI [2,1])
C0022423 (UMLS CUI [2,2])
C0679823 (UMLS CUI [2,3])
C1518422 (UMLS CUI [2,4])
C0034866 (UMLS CUI [2,5])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial